{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:37:35Z","timestamp":1785375455237,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To evaluate the outcomes of three-dimensional (3D) heads-up system assisted pars plana vitrectomy (PPV) and subretinal injection of recombinant tissue plasminogen activator (rt-PA) for submacular hemorrhage (SMH).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Medical records of SMH patients who underwent 3D heads-up system assisted-PPV and subretinal injection of rt-PA from June 2021 to January 2022 were reviewed. The main outcomes included best-corrected visual acuity (BCVA), SMH absorption, and perioperative complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We finally included 18 SMH eyes, most of which happened secondary to polypoidal choroidal vasculopathy (PCV) (10, 55.56%), followed by retinal arterial microaneurysm (RAM) (5, 27.78%), traumatic retinopathy (2, 11.11%) and neovascular age-related macular degeneration (nAMD) (1, 5.56%). The greatest linear dimension (GLD) and height of SMH were 6538.17\u2009\u00b1\u20092533.11\u00a0\u03bcm and 937.36\u2009\u00b1\u2009420.21\u00a0\u03bcm, respectively. After an average postoperative follow-up period of 131.06\u2009\u00b1\u200938.96\u00a0days, patients\u2019 BCVA improved significantly from 1.85\u2009\u00b1\u20090.62 to 1.14\u2009\u00b1\u20090.82 logMAR (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). SMH was completely and partially absorbed in 9 (50.00%) and 6 (33.33%) eyes, with no occurrence of iatrogenic retinal break. However, 4 additional PPVs were performed to manage the postoperative SMH and\/or vitreous hemorrhage (VH) recurrence (2, 11.11%) and retinal detachment (RD) occurrence (2, 11.11%). Preoperative BCVA was significantly correlated with postoperative BCVA in multiple linear regression analysis (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), and hemorrhagic pigment epithelial detachment (PED) was significantly correlated with SMH and VH recurrence in univariate binary logistic regression analysis (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The 3D heads-up system assisted-PPV and subretinal injection of rt-PA were efficacious in eliminating SMH and improving visual prognosis with satisfactory safety profile, while caution should be taken for PCV patients with hemorrhagic PED and massive SMH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40662-023-00326-5","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T01:02:46Z","timestamp":1677632566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Three-dimensional heads-up system assisted pars plana vitrectomy and subretinal recombinant tissue plasminogen activator injection for submacular hemorrhage"],"prefix":"10.1186","volume":"10","author":[{"given":"Xinyu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-5058","authenticated-orcid":false,"given":"Youxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyi","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"issue":"6","key":"326_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/0002-9394(82)90301-4","volume":"94","author":"H Glatt","year":"1982","unstructured":"Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94(6):762\u201373.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"326_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/archopht.1991.01080050139046","volume":"109","author":"CA Toth","year":"1991","unstructured":"Toth CA, Morse LS, Hjelmeland LM, Landers MB 3rd. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol. 1991;109(5):723\u20139.","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"326_CR3","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0161-6420(01)00648-0","volume":"108","author":"LO Hattenbach","year":"2001","unstructured":"Hattenbach LO, Klais C, Koch FH, G\u00fcmbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology. 2001;108(8):1485\u201392.","journal-title":"Ophthalmology"},{"issue":"3","key":"326_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00006982-199616030-00001","volume":"16","author":"RL Avery","year":"1996","unstructured":"Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16(3):183\u20139.","journal-title":"Retina"},{"issue":"5","key":"326_CR5","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1177\/1120672120970404","volume":"31","author":"S Saito-Uchida","year":"2021","unstructured":"Saito-Uchida S, Inoue M, Koto T, Kato Y, Hirakata A. Vitrectomy combined with subretinal injection of tissue plasminogen activator for successful treatment of massive subretinal hemorrhage. Eur J Ophthalmol. 2021;31(5):2588\u201395.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"326_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10384-019-00679-2","volume":"63","author":"S Kimura","year":"2019","unstructured":"Kimura S, Morizane Y, Hosokawa MM, Shiode Y, Doi S, Hosogi M, et al. Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy. Jpn J Ophthalmol. 2019;63(5):382\u20138.","journal-title":"Jpn J Ophthalmol."},{"issue":"6","key":"326_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s10384-017-0530-0","volume":"61","author":"S Kimura","year":"2017","unstructured":"Kimura S, Morizane Y, Matoba R, Hosokawa M, Shiode Y, Hirano M, et al. Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: effectiveness and safety of subretinal tissue plasminogen activator. Jpn J Ophthalmol. 2017;61(6):472\u20138.","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"326_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/IAE.0000000000000689","volume":"36","author":"C Eckardt","year":"2016","unstructured":"Eckardt C, Paulo EB. Heads-up surgery for vitreoretinal procedures: an experimental and clinical study. Retina. 2016;36(1):137\u201347.","journal-title":"Retina"},{"issue":"9","key":"326_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/tvst.10.9.4","volume":"10","author":"K Wang","year":"2021","unstructured":"Wang K, Song F, Zhang L, Xu J, Zhong Y, Lu B, et al. Three-dimensional heads-up cataract surgery using femtosecond laser: efficiency, efficacy, safety, and medical education-a randomized clinical trial. Transl Vis Sci Technol. 2021;10(9):4.","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"326_CR10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41433-018-0027-1","volume":"32","author":"MR Romano","year":"2018","unstructured":"Romano MR, Cennamo G, Comune C, Cennamo M, Ferrara M, Rombetto L, et al. Evaluation of 3D heads-up vitrectomy: outcomes of psychometric skills testing and surgeon satisfaction. Eye (Lond). 2018;32(6):1093\u20138.","journal-title":"Eye (Lond)"},{"key":"326_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40942-017-0099-2","volume":"3","author":"M Coppola","year":"2017","unstructured":"Coppola M, La Spina C, Rabiolo A, Querques G, Bandello F. Heads-up 3D vision system for retinal detachment surgery. Int J Retina Vitreous. 2017;3:46.","journal-title":"Int J Retina Vitreous"},{"issue":"8","key":"326_CR12","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1097\/IAE.0000000000001743","volume":"38","author":"N Chhaya","year":"2018","unstructured":"Chhaya N, Helmy O, Piri N, Palacio A, Schaal S. Comparison of 2D and 3D video displays for teaching vitreoretinal surgery. Retina. 2018;38(8):1556\u201361.","journal-title":"Retina"},{"issue":"4","key":"326_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/IAE.0000000000002018","volume":"38","author":"S Rizzo","year":"2018","unstructured":"Rizzo S, Abbruzzese G, Savastano A, Giansanti F, Caporossi T, Barca F, et al. 3D Surgical viewing system in ophthalmology: perceptions of the surgical team. Retina. 2018;38(4):857\u201361.","journal-title":"Retina"},{"key":"326_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-022-05850-z","author":"XY Zhao","year":"2022","unstructured":"Zhao XY, Zhao Q, Li NN, Meng LH, Zhang WF, Wang EQ, et al. Surgery-related characteristics, efficacy, safety and surgical team satisfaction of three-dimensional heads-up system versus traditional microscopic equipment for various vitreoretinal diseases. Graefes Arch Clin Exp Ophthalmol. 2022. https:\/\/doi.org\/10.1007\/s00417-022-05850-z.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"326_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/IAE.0b013e3181c969cb","volume":"30","author":"T Sakamoto","year":"2010","unstructured":"Sakamoto T, Sheu SJ, Arimura N, Sameshima S, Shimura M, Uemura A, et al. Vitrectomy for exudative age-related macular degeneration with vitreous hemorrhage. Retina. 2010;30(6):856\u201364.","journal-title":"Retina"},{"issue":"12","key":"326_CR16","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/archopht.1991.01080120115039","volume":"109","author":"JD Benner","year":"1991","unstructured":"Benner JD, Morse LS, Toth CA, Landers MB 3rd, Hjelmeland LM. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat. Arch Ophthalmol. 1991;109(12):1731\u20136.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"326_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00417-009-1158-7","volume":"248","author":"J Hillenkamp","year":"2010","unstructured":"Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. 2010;248(1):5\u201311.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"326_CR18","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41433-020-0783-6","volume":"34","author":"S Tiew","year":"2020","unstructured":"Tiew S, Lim C, Sivagnanasithiyar T. Using an excel spreadsheet to convert Snellen visual acuity to LogMAR visual acuity. Eye (Lond). 2020;34(11):2148\u20139.","journal-title":"Eye (Lond)"},{"issue":"3","key":"326_CR19","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236\u201340.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"16","key":"326_CR20","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.3390\/jcm11164717","volume":"11","author":"C Irigoyen","year":"2022","unstructured":"Irigoyen C, Amenabar Alonso A, Sanchez-Molina J, Rodr\u00edguez-Hidalgo M, Lara-L\u00f3pez A, Ruiz-Ederra J. Subretinal injection techniques for retinal disease: a review. J Clin Med. 2022;11(16):4717.","journal-title":"J Clin Med"},{"issue":"5","key":"326_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.matbio.2010.03.004","volume":"29","author":"J Candiello","year":"2010","unstructured":"Candiello J, Cole GJ, Halfter W. Age-dependent changes in the structure, composition and biophysical properties of a human basement membrane. Matrix Biol. 2010;29(5):402\u201310.","journal-title":"Matrix Biol"},{"issue":"11","key":"326_CR22","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/eye.2013.178","volume":"27","author":"C Haritoglou","year":"2013","unstructured":"Haritoglou C, Mauell S, Benoit M, Schumann RG, Henrich PB, Wolf A, et al. Vital dyes increase the rigidity of the internal limiting membrane. Eye (Lond). 2013;27(11):1308\u201315.","journal-title":"Eye (Lond)"},{"issue":"5","key":"326_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/IAE.0000000000001029","volume":"36","author":"T Okanouchi","year":"2016","unstructured":"Okanouchi T, Toshima S, Kimura S, Morizane Y, Shiraga F. Novel technique for subretinal injection using local removal of the internal limiting membrane. Retina. 2016;36(5):1035\u20138.","journal-title":"Retina"},{"issue":"2","key":"326_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/IIO.0000000000000018","volume":"54","author":"FF Malik","year":"2014","unstructured":"Malik FF, Poulaki V. Management of submacular hemorrhage. Int Ophthalmol Clin. 2014;54(2):51\u20139.","journal-title":"Int Ophthalmol Clin"},{"issue":"12","key":"326_CR25","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1007\/s10792-021-01976-x","volume":"41","author":"P Tranos","year":"2021","unstructured":"Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review. Int Ophthalmol. 2021;41(12):4037\u201346.","journal-title":"Int Ophthalmol"},{"issue":"5","key":"326_CR26","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/IAE.0000000000000954","volume":"36","author":"JH de Jong","year":"2016","unstructured":"de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, et al. Intravitreal versus subretinal administration of recombinant tissue plasminogen activator combined with gas for acute submacular hemorrhages due to age-related macular degeneration: an exploratory prospective study. Retina. 2016;36(5):914\u201325.","journal-title":"Retina"},{"issue":"6","key":"326_CR27","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.ophtha.2016.01.035","volume":"123","author":"Y Kitagawa","year":"2016","unstructured":"Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M. Intravitreal tissue plasminogen activator, ranibizumab, and gas injection for submacular hemorrhage in polypoidal choroidal vasculopathy. Ophthalmology. 2016;123(6):1278\u201386.","journal-title":"Ophthalmology"},{"issue":"9","key":"326_CR28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00417-002-0516-5","volume":"240","author":"SD Schulze","year":"2002","unstructured":"Schulze SD, Hesse L. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome. Graefes Arch Clin Exp Ophthalmol. 2002;240(9):717\u201320.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"326_CR29","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1097\/IAE.0000000000000574","volume":"35","author":"T Hirashima","year":"2015","unstructured":"Hirashima T, Moriya T, Bun T, Utsumi T, Hirose M, Oh H. Optical coherence tomography findings and surgical outcomes of tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage secondary to age-related macular degeneration. Retina. 2015;35(10):1969\u201378.","journal-title":"Retina"},{"issue":"6","key":"326_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ophtha.2003.10.020","volume":"111","author":"S Olivier","year":"2004","unstructured":"Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology. 2004;111(6):1201\u20138.","journal-title":"Ophthalmology"},{"issue":"1","key":"326_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ophtha.2014.07.027","volume":"122","author":"K Kadonosono","year":"2015","unstructured":"Kadonosono K, Arakawa A, Yamane S, Inoue M, Yamakawa T, Uchio E, et al. Displacement of submacular hemorrhages in age-related macular degeneration with subretinal tissue plasminogen activator and air. Ophthalmology. 2015;122(1):123\u20138.","journal-title":"Ophthalmology"},{"issue":"10","key":"326_CR32","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/IAE.0b013e3181e2263c","volume":"30","author":"HF Fine","year":"2010","unstructured":"Fine HF, Iranmanesh R, Del Priore LV, Barile GR, Chang LK, Chang S, et al. Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration. Retina. 2010;30(10):1588\u201394.","journal-title":"Retina"},{"issue":"3","key":"326_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.oret.2017.07.012","volume":"2","author":"S Sharma","year":"2018","unstructured":"Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, et al. Pneumatic displacement of submacular hemorrhage with subretinal air and tissue plasminogen activator: initial United States experience. Ophthalmol Retina. 2018;2(3):180\u20136.","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"326_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/bjo.2009.164707","volume":"94","author":"F Treumer","year":"2010","unstructured":"Treumer F, Klatt C, Roider J, Hillenkamp J. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage. Br J Ophthalmol. 2010;94(1):48\u201353.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"326_CR35","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00417-014-2861-6","volume":"253","author":"M Inoue","year":"2015","unstructured":"Inoue M, Shiraga F, Shirakata Y, Morizane Y, Kimura S, Hirakata A. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm. Graefes Arch Clin Exp Ophthalmol. 2015;253(10):1663\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"326_CR36","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1097\/IAE.0000000000003098","volume":"41","author":"XY Zhao","year":"2021","unstructured":"Zhao XY, Luo MY, Meng LH, Zhang WF, Li B, Wang EQ, et al. The incidence, characteristics, management, prognosis, and classification of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy. Retina. 2021;41(8):1675\u201385.","journal-title":"Retina"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-023-00326-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-023-00326-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-023-00326-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T01:05:28Z","timestamp":1677632728000},"score":1,"resource":{"primary":{"URL":"https:\/\/eandv.biomedcentral.com\/articles\/10.1186\/s40662-023-00326-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1186\/s40662-023-00326-5","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"28 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the Institutional Review Board\/Ethics Committee of Peking Union Medical College Hospital (No. S-K1993). Written informed consent was obtained from each patient before the surgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study subjects whose fundus photograph and SS-OCT were reported in this manuscript gave informed consent and signed the informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}